Edition:
United States

Infinity Pharmaceuticals Inc (INFI.O)

INFI.O on Nasdaq

1.39USD
12:23pm EDT
Change (% chg)

$0.06 (+4.51%)
Prev Close
$1.33
Open
$1.30
Day's High
$1.42
Day's Low
$1.30
Volume
139,897
Avg. Vol
638,054
52-wk High
$3.84
52-wk Low
$0.84

INFI.O

Chart for INFI.O

About

Infinity Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in the discovery, development and delivery of medicines to treat diseases. The Company develops small molecule drugs that target disease pathways for potential applications in oncology. Its product candidate is duvelisib, also known as IPI-145,... (more)

Overall

Beta: 2.57
Market Cap(Mil.): $67.09
Shares Outstanding(Mil.): 50.44
Dividend: --
Yield (%): --

Financials

  INFI.O Industry Sector
P/E (TTM): 101.92 219.31 16.47
EPS (TTM): 0.01 -- --
ROI: 0.07 -8.84 -8.42
ROE: 0.13 -10.89 -8.02

BRIEF-Infinity amends PI3K-Delta,Gamma Agreement with Takeda Oncology

* Infinity amends PI3K-Delta,Gamma Agreement with Takeda Oncology

Jul 27 2017

BRIEF-Infinity reports Q1 loss per share $0.21

* Infinity provides company update and reports first quarter 2017 financial results

May 09 2017

BRIEF-Infinity expects net loss for 2017 to range from $40 mln-$50 mln

* Infinity provides company update and reports fourth quarter 2016 financial results

Mar 14 2017

Earnings vs. Estimates